Microbix Biosystems Inc. (TSE:MBX – Get Rating) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$0.42 and traded as low as C$0.38. Microbix Biosystems shares last traded at C$0.39, with a volume of 6,000 shares trading hands.
Microbix Biosystems Price Performance
The stock’s 50-day moving average price is C$0.42 and its 200 day moving average price is C$0.48. The firm has a market cap of C$53.51 million and a price-to-earnings ratio of 19.25. The company has a quick ratio of 5.57, a current ratio of 7.84 and a debt-to-equity ratio of 23.60.
Microbix Biosystems (TSE:MBX – Get Rating) last posted its earnings results on Thursday, December 22nd. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$4.33 million for the quarter, compared to analyst estimates of C$5.10 million. Equities research analysts predict that Microbix Biosystems Inc. will post 0.0404762 earnings per share for the current year.
About Microbix Biosystems
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices.
Read More
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.